Bagsværd, Denmark, 23 February 2016 - The Annual General Meeting of Novo Nordisk A/S will be held on:
Friday 18 March 2016 at 2.00 pm (CET)
at Bella Center, entrance West, Center Boulevard 5, 2300 Copenhagen S, Denmark.
The notice for the Annual General Meeting, including Appendix 1: Candidates for the Board of Directors and Appendix 2: Revised Remuneration Principles, is enclosed.
Further information
Media: | ||
Katrine Sperling | +45 3079 6718 | krsp@novonordisk.com (mailto:krsp@novonordisk.com) |
Ken Inchausti (US) | +1 267 809 7552 | kiau@novonordisk.com (mailto:mailtokiau@novonordisk.com) |
Investors: | ||
Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com (mailto:phak@novonordisk.com) |
Daniel Bohsen | +45 3079 6376 | dabo@novonordisk.com (mailto:dabo@novonordisk.com) |
Melanie Raouzeos | +45 3075 3479 | mrz@novonordisk.com (mailto:mrz@novonordisk.com) |
Kasper Veje | +45 3079 8519 | kpvj@novonordisk.com (mailto:kpvj@novonordisk.com) |
Company announcement No 16 / 2016
Company announcement No 16 / 2016 (http://hugin.info/2013/R/1988158/729913.pdf)
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire
HUG#1988158